SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes

European Journal of Cancer

Volumn 48, Issue 10, 2012, Pages 1550-1557

  Kocic, Jelena ^a   Bugarski, Diana ^a   Santibanez, Juan F ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

E cadherin; Migration; PAI 1; Smad3; TGF 1; uPA

Indexed keywords

PROTEIN INHIBITOR; SB 505124; SIS3; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UROKINASE; UVOMORULIN;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; CADHERINS; CELL MOVEMENT; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84862025999     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.06.043     Document Type: Article

References (40)

1. A.B. Roberts, and L.M. Wakefield The two faces of transforming growth factor beta in carcinogenesis Proc Natl Acad Sci USA 100 2003 8621 8623
2. C. Caulin, F.G. Scholl, P. Frontelo, C. Gamallo, and M. Quintanilla Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype Cell Growth Differ 6 1995 1027 1035
3. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 2002 442 454
4. L.M. Wakefield, and A.B. Roberts TGF-beta signaling: positive and negative effects on tumorigenesis Curr Opin Genet Dev 12 2002 22 29
5. P. Wikstrom, P. Stattin, I. Franck-Lissbrant, J.E. Damber, and A. Bergh Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer Prostate 37 1998 19 29
6. R. Derynck, and Y.E. Zhang Smad-dependent and Smad-independent pathways in TGFbeta family signalling Nature 425 2003 577 584
7. M.J. Duffy, P.M. McGowan, and W.M. Gallagher Cancer invasion and metastasis: changing views J Pathol 214 2008 283 293
8. M.J. Duffy Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers Biochem Soc Trans 30 2002 207 210
9. M. Jo, K.S. Thomas, and N. Marozkina Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator J Biol Chem 280 2005 17449 17457
10. E. Planus, G. Barlovatz-Meimon, and R.A. Rogers Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading J Cell Sci 110 1997 1091 1098
11. D.Q. Seetoo, P.J. Crowe, P.J. Russell, and J.L. Yang Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer J Surg Oncol 82 2003 184 193
12. N. Harbeck, R.E. Kates, and M. Schmitt Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer Clin Breast Cancer 5 2004 348 352
13. L. Yang, C. Mao, and Y. Teng Targeted disruption of Smad4 in mouse epidermis results in failure of hair follicle cycling and formation of skin tumors Cancer Res 65 2005 8671 8678
14. K.E. Hoot, J. Lighthall, and G. Han Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression J Clin Invest 118 2008 2722 2732
15. A.B. Roberts, F. Tian, and S.D. Byfield Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis Cytokine Growth Factor Rev 17 2006 19 27
16. S.W. Lin, F.C. Ke, and P.W. Hsiao Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system Exp Cell Res 313 2007 602 613
17. N. Tobar, V. Villar, and J.F. Santibanez ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion Mol Cell Biochem 340 2010 195 202
18. J.F. Santibáñez, M. Iglesias, P. Frontelo, J. Martínez, and M. Quintanilla Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes Biochem Biophys Res Commun 273 2000 521 527
19. J.F. Santibañez JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes FEBS Lett 580 2006 5385 5389
20. S.R. Shiou, P.K. Datta, and P. Dhawan Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta J Biol Chem 281 2006 33971 33981
21. I. Schwarte-Waldhoff, S. Klein, and S. Blass-Kampmann DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression Oncogene 18 1999 3152 3158
22. J.F. Santibáñez, P. Frontelo, M. Iglesias, J. Martínez, and M. Quintanilla Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes J Cell Biochem 74 1999 61 73
23. J.F. Santibanez, A. Letamendia, and F. Perez-Barriocanal Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling J Cell Physiol 210 2007 456 468
24. V. Villar, J. Kocic, D. Bugarski, G. Jovcic, and J.F. Santibanez SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes FEBS Lett 584 2010 4586 4592
25. V. Villar, J. Kocić, and J.F. Santibanez Spred2 inhibits TGF-beta1-induced urokinase type plasminogen activator expression, cell motility and epithelial mesenchymal transition Int J Cancer 127 2010 77 85
26. T. Watabe, A. Nishihara, and K. Mishima TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells J Cell Biol 163 2003 1303 1311
27. M. Jo, R.D. Lester, and V. Montel Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling J Biol Chem 284 2009 22825 22833
28. O.D. Gil, C. Lee, and E.V. Ariztia Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner Gynecol Oncol 108 2008 361 369
29. A. Cano, M.A. Pérez-Moreno, and I. Rodrigo The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression Nat Cell Biol 2 2000 76 83
30. O. Shinto, M. Yashiro, and T. Toyokawa Phosphorylated smad2 in advanced stage gastric carcinoma BMC Cancer 10 2010 652
31. P. Papageorgis, A.W. Lambert, and S. Ozturk Smad signaling is required to maintain epigenetic silencing during breast cancer progression Cancer Res 70 2011 968 978
32. P.R. Arany, S.G. Rane, and A.B. Roberts Smad3 deficiency inhibits v-ras-induced transformation by suppression of JNK MAPK signaling and increased farnesyl transferase inhibition Oncogene 27 2008 2507 2512
33. G.S. Ashcroft, and A.B. Roberts Loss of Smad3 modulates wound healing Cytokine Growth Factor Rev 11 2000 125 131
34. F. Blasi Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system Thromb Haemost 82 1999 298 304
35. F. Li, J. Goncalves, K. Faughnan, and M.G. Steiner Targeted inhibition of wound-induced PAI-1 expression alters migration and differentiation in human epidermal keratinocytes Exp Cell Res 258 2000 245 253
36. J. Freytag, C.E. Wilkins-Port, and C.E. Higgins PAI-1 regulates the invasive phenotype in human cutaneous squamous cell carcinoma J Oncol 2009 2009 963209
37. M. Petersen, E. Pardali, and G. van der Horst Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis Oncogene 29 2010 1351 1361
38. H. Peinado, E. Ballestar, M. Esteller, and A. Cano Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex Mol Cell Biol 24 2004 306 319
39. T. Vincent, E.P. Neve, and J.R. Johnson A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition Nat Cell Biol 11 2009 943 950
40. E. Fabre-Guillevin, M. Malo, and A. Cartier-Michaud PAI-1 and functional blockade of SNAI1 in breast cancer cell migration Breast Cancer Res 10 6 2008 R100